We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SHW:NYSESherwin-Williams Company (The) analysis

Data as of Oct 15, 2026 - not real-time

Latest price
$336.69
Risk: medium
4/10Medium risk

Summary

The Sherwin-Williams Company trades at $336.69, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it gained 1.6%. RSI sits at 60.4, which reads as approaching overbought, and MACD momentum is bullish. Watch $311.12 as support and $339.77 as the nearer resistance level.
Multiples put this in overvalued territory at a P/E of 31.0. Consensus targets land 13.8% above where the shares trade now. Revenue is growing at 7.5% on a 11.0% profit margin. The 0.99% dividend yield looks covered by current payout levels.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 22.8%, a beta of 0.87 and a maximum drawdown of 21.4%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top market events

  • Wrapping up Q2 earnings, we look at the numbers and key takeaways for the building materials stocks, including...
  • Wrapping up Q2 earnings, we look at the numbers and key takeaways for the building materials stocks, including...
  • Second-quarter revenue rose 7.50 percent year over year. Sherwin-Williams stock costs EUR 284.90 in

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • Trading above the 200-day average of 333.12
  • MACD momentum is positive
  • Maximum drawdown of 21.4%

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Trading above the 200-day average of 333.12
  • Analyst targets imply +13.8% versus the current price
  • MACD momentum is positive

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • Analyst targets imply +13.8% versus the current price
  • P/E ratio of 31.0
  • Return on equity of 65.1%

Key metrics

Financial health

Revenue Growth7.50%
Profit Margin11.01%
P/E Ratio31.0
ROE65.12%
ROA9.52%
Debt/Equity389.96
P/B Ratio21.1
Op. Cash Flow$3.9B
Free Cash Flow$2.5B

Technical analysis

TrendNeutral
RSI60.4
Support$311.12
Resistance$339.77
MA 20$323.68
MA 50$334.73
MA 200$333.12
MACDBullish
VolumeDecreasing
Fear & Greed Index92.05

Valuation

Fair Value$108.40
Target Price$383.13
Upside/Downside13.79%
GradeOvervalued
TypeGrowth
Dividend Yield0.99%

Risk assessment

Beta0.87
Volatility22.82%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.